Physician profile
Clyde E Glenn
NPI 1982612164
$68,498.12
in general payments reported to CMS, 2019-2025
6 companies · $66K in 2025
The $66K reported for 2025 was more than what 98% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2022: $12.19 · 2023: $89.39 · 2024: $2,045 · 2025: $66K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $62K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,410 · Travel and Lodging: $1,812 · Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $62,486.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,410.00 |
| Travel and Lodging | $1,811.56 |
| Food and Beverage | $446.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67,941.38 | 2024-2025 | |
| Allergan, INC. | $140.94 | 2019 | |
| Axsome Therapeutics, INC. | $124.22 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $110.67 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $91.52 | 2019 | |
| Biogen, INC. | $89.39 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clyde Glenn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.